Anixa Biosciences, Inc. (ANIX)
3.28
-0.07
(-2.09%)
USD |
NASDAQ |
Sep 01, 16:00
3.265
-0.02
(-0.46%)
After-Hours: 20:00
Anixa Biosciences Research and Development Expense (Annual) : 5.071M for Oct. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| October 31, 2025 | 5.071M |
| October 31, 2024 | 6.396M |
| October 31, 2023 | 4.769M |
| October 31, 2022 | 6.703M |
| October 31, 2021 | 6.190M |
| October 31, 2020 | 4.381M |
| October 31, 2019 | 5.426M |
| October 31, 2018 | 6.813M |
| October 31, 2017 | 1.598M |
| October 31, 2016 | 1.556M |
| October 31, 2015 | |
| October 31, 2014 | |
| October 31, 2013 | 0.00 |
| October 31, 2012 | 2.212M |
| October 31, 2011 | 3.125M |
| October 31, 2010 | 3.008M |
| October 31, 2009 | 4.116M |
| October 31, 2008 | 4.127M |
| Date | Value |
|---|---|
| October 31, 2007 | 3.404M |
| October 31, 2006 | 4.614M |
| October 31, 2005 | 2.267M |
| October 31, 2004 | 2.164M |
| October 31, 2003 | 1.808M |
| October 31, 2002 | 1.626M |
| October 31, 2001 | 2.325M |
| October 31, 2000 | 2.732M |
| October 31, 1999 | 3.163M |
| October 31, 1998 | 3.926M |
| October 31, 1997 | 3.385M |
| October 31, 1996 | 3.732M |
| October 31, 1995 | 2.290M |
| October 31, 1994 | 2.621M |
| October 31, 1993 | 1.752M |
| October 31, 1992 | 1.200M |
| October 31, 1991 | 0.8857M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 585.26M |
| Oncolytics Biotech, Inc. | 13.31M |
| Sangamo Therapeutics, Inc. | 112.67M |
| Sarepta Therapeutics, Inc. | 1.493B |
| Vicapsys Life Sciences, Inc. | 0.0006M |